| UniProt ID | UBP10_HUMAN | |
|---|---|---|
| UniProt AC | Q14694 | |
| Protein Name | Ubiquitin carboxyl-terminal hydrolase 10 | |
| Gene Name | USP10 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 798 | |
| Subcellular Localization | Cytoplasm . Nucleus . Early endosome . Cytoplasmic in normal conditions (PubMed:20096447). After DNA damage, translocates to the nucleus following phosphorylation by ATM (PubMed:20096447). | |
| Protein Description | Hydrolase that can remove conjugated ubiquitin from target proteins such as p53/TP53, BECN1, SNX3 and CFTR. Acts as an essential regulator of p53/TP53 stability: in unstressed cells, specifically deubiquitinates p53/TP53 in the cytoplasm, leading to counteract MDM2 action and stabilize p53/TP53. Following DNA damage, translocates to the nucleus and deubiquitinates p53/TP53, leading to regulate the p53/TP53-dependent DNA damage response. Component of a regulatory loop that controls autophagy and p53/TP53 levels: mediates deubiquitination of BECN1, a key regulator of autophagy, leading to stabilize the PIK3C3/VPS34-containing complexes. In turn, PIK3C3/VPS34-containing complexes regulate USP10 stability, suggesting the existence of a regulatory system by which PIK3C3/VPS34-containing complexes regulate p53/TP53 protein levels via USP10 and USP13. Does not deubiquitinate MDM2. Deubiquitinates CFTR in early endosomes, enhancing its endocytic recycling. Involved in a TANK-dependent negative feedback response to attenuate NF-kappaB activation via deubiquitinating IKBKG or TRAF6 in response to interleukin-1-beta (IL1B) stimulation or upon DNA damage. [PubMed: 25861989 Deubiquitinates TBX21 leading to its stabilization] | |
| Protein Sequence | MALHSPQYIFGDFSPDEFNQFFVTPRSSVELPPYSGTVLCGTQAVDKLPDGQEYQRIEFGVDEVIEPSDTLPRTPSYSISSTLNPQAPEFILGCTASKITPDGITKEASYGSIDCQYPGSALALDGSSNVEAEVLENDGVSGGLGQRERKKKKKRPPGYYSYLKDGGDDSISTEALVNGHANSAVPNSVSAEDAEFMGDMPPSVTPRTCNSPQNSTDSVSDIVPDSPFPGALGSDTRTAGQPEGGPGADFGQSCFPAEAGRDTLSRTAGAQPCVGTDTTENLGVANGQILESSGEGTATNGVELHTTESIDLDPTKPESASPPADGTGSASGTLPVSQPKSWASLFHDSKPSSSSPVAYVETKYSPPAISPLVSEKQVEVKEGLVPVSEDPVAIKIAELLENVTLIHKPVSLQPRGLINKGNWCYINATLQALVACPPMYHLMKFIPLYSKVQRPCTSTPMIDSFVRLMNEFTNMPVPPKPRQALGDKIVRDIRPGAAFEPTYIYRLLTVNKSSLSEKGRQEDAEEYLGFILNGLHEEMLNLKKLLSPSNEKLTISNGPKNHSVNEEEQEEQGEGSEDEWEQVGPRNKTSVTRQADFVQTPITGIFGGHIRSVVYQQSSKESATLQPFFTLQLDIQSDKIRTVQDALESLVARESVQGYTTKTKQEVEISRRVTLEKLPPVLVLHLKRFVYEKTGGCQKLIKNIEYPVDLEISKELLSPGVKNKNFKCHRTYRLFAVVYHHGNSATGGHYTTDVFQIGLNGWLRIDDQTVKVINQYQVVKPTAERTAYLLYYRRVDLL | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Acetylation | ------MALHSPQYI ------CCCCCCCEE | 17.62 | 20068231 | |
| 5 | Phosphorylation | ---MALHSPQYIFGD ---CCCCCCCEECCC | 17.97 | 25159151 | |
| 8 | Phosphorylation | MALHSPQYIFGDFSP CCCCCCCEECCCCCH | 11.12 | 28450419 | |
| 14 | Phosphorylation | QYIFGDFSPDEFNQF CEECCCCCHHHHHCC | 35.86 | 28464451 | |
| 24 | Phosphorylation | EFNQFFVTPRSSVEL HHHCCEECCCCCCCC | 14.08 | 20068231 | |
| 27 | Phosphorylation | QFFVTPRSSVELPPY CCEECCCCCCCCCCC | 39.68 | 25159151 | |
| 28 | Phosphorylation | FFVTPRSSVELPPYS CEECCCCCCCCCCCC | 22.38 | 25159151 | |
| 32 | Phosphorylation | PRSSVELPPYSGTVL CCCCCCCCCCCCEEE | 16.57 | 27251275 | |
| 34 | Phosphorylation | SSVELPPYSGTVLCG CCCCCCCCCCEEEEC | 20.14 | 27251275 | |
| 35 | Phosphorylation | SVELPPYSGTVLCGT CCCCCCCCCEEEECC | 33.49 | 27251275 | |
| 37 | Phosphorylation | ELPPYSGTVLCGTQA CCCCCCCEEEECCEE | 12.36 | 27251275 | |
| 42 | Phosphorylation | SGTVLCGTQAVDKLP CCEEEECCEEEECCC | 16.62 | 28796482 | |
| 47 | Acetylation | CGTQAVDKLPDGQEY ECCEEEECCCCCCEE | 56.15 | 26051181 | |
| 54 | Phosphorylation | KLPDGQEYQRIEFGV CCCCCCEEEEEECCC | 8.66 | 28796482 | |
| 68 | Phosphorylation | VDEVIEPSDTLPRTP CCCEECCCCCCCCCC | 30.36 | 28387310 | |
| 70 | Phosphorylation | EVIEPSDTLPRTPSY CEECCCCCCCCCCCC | 42.89 | 26074081 | |
| 74 | Phosphorylation | PSDTLPRTPSYSISS CCCCCCCCCCCCCCC | 18.04 | 23401153 | |
| 76 | Phosphorylation | DTLPRTPSYSISSTL CCCCCCCCCCCCCCC | 30.79 | 21945579 | |
| 77 | Phosphorylation | TLPRTPSYSISSTLN CCCCCCCCCCCCCCC | 15.95 | 21945579 | |
| 78 | Phosphorylation | LPRTPSYSISSTLNP CCCCCCCCCCCCCCC | 21.97 | 21945579 | |
| 80 | Phosphorylation | RTPSYSISSTLNPQA CCCCCCCCCCCCCCC | 16.01 | 21945579 | |
| 81 | Phosphorylation | TPSYSISSTLNPQAP CCCCCCCCCCCCCCC | 34.93 | 21945579 | |
| 82 | Phosphorylation | PSYSISSTLNPQAPE CCCCCCCCCCCCCCC | 24.62 | 21945579 | |
| 94 | Glutathionylation | APEFILGCTASKITP CCCEEEEEECCCCCC | 2.29 | 22555962 | |
| 95 | Phosphorylation | PEFILGCTASKITPD CCEEEEEECCCCCCC | 31.97 | 21945579 | |
| 97 | Phosphorylation | FILGCTASKITPDGI EEEEEECCCCCCCCC | 13.36 | 21945579 | |
| 100 | Phosphorylation | GCTASKITPDGITKE EEECCCCCCCCCCCE | 21.04 | 30266825 | |
| 104 | Phosphorylation | SKITPDGITKEASYG CCCCCCCCCCEECCC | 6.92 | 27251275 | |
| 105 | Phosphorylation | KITPDGITKEASYGS CCCCCCCCCEECCCC | 28.50 | 24732914 | |
| 109 | Phosphorylation | DGITKEASYGSIDCQ CCCCCEECCCCCCCC | 30.99 | 28348404 | |
| 110 | Phosphorylation | GITKEASYGSIDCQY CCCCEECCCCCCCCC | 23.18 | 28102081 | |
| 112 | Phosphorylation | TKEASYGSIDCQYPG CCEECCCCCCCCCCC | 13.66 | 28348404 | |
| 116 | Phosphorylation | SYGSIDCQYPGSALA CCCCCCCCCCCCEEE | 43.65 | 27251275 | |
| 117 | Phosphorylation | YGSIDCQYPGSALAL CCCCCCCCCCCEEEE | 18.85 | 28102081 | |
| 120 | Phosphorylation | IDCQYPGSALALDGS CCCCCCCCEEEECCC | 18.66 | 28102081 | |
| 127 | Phosphorylation | SALALDGSSNVEAEV CEEEECCCCCEEEEE | 20.57 | 28348404 | |
| 128 | Phosphorylation | ALALDGSSNVEAEVL EEEECCCCCEEEEEH | 50.88 | 28348404 | |
| 154 | Ubiquitination | RERKKKKKRPPGYYS HHHHCCCCCCCCHHH | 78.13 | - | |
| 159 | Phosphorylation | KKKRPPGYYSYLKDG CCCCCCCHHHHCCCC | 8.60 | 21945579 | |
| 160 | Phosphorylation | KKRPPGYYSYLKDGG CCCCCCHHHHCCCCC | 9.21 | 21945579 | |
| 161 | Phosphorylation | KRPPGYYSYLKDGGD CCCCCHHHHCCCCCC | 18.59 | 21945579 | |
| 162 | Phosphorylation | RPPGYYSYLKDGGDD CCCCHHHHCCCCCCC | 11.14 | 21945579 | |
| 203 | Phosphorylation | FMGDMPPSVTPRTCN HHCCCCCCCCCCCCC | 32.52 | 26471730 | |
| 205 | Phosphorylation | GDMPPSVTPRTCNSP CCCCCCCCCCCCCCC | 16.05 | 18669648 | |
| 208 | Phosphorylation | PPSVTPRTCNSPQNS CCCCCCCCCCCCCCC | 19.76 | 29255136 | |
| 209 | Phosphorylation | PSVTPRTCNSPQNST CCCCCCCCCCCCCCC | 5.11 | 27251275 | |
| 211 | Phosphorylation | VTPRTCNSPQNSTDS CCCCCCCCCCCCCCC | 29.97 | 29255136 | |
| 215 | Phosphorylation | TCNSPQNSTDSVSDI CCCCCCCCCCCHHHC | 28.48 | 29255136 | |
| 216 | Phosphorylation | CNSPQNSTDSVSDIV CCCCCCCCCCHHHCC | 39.58 | 23927012 | |
| 218 | Phosphorylation | SPQNSTDSVSDIVPD CCCCCCCCHHHCCCC | 24.49 | 30278072 | |
| 220 | Phosphorylation | QNSTDSVSDIVPDSP CCCCCCHHHCCCCCC | 26.10 | 20201521 | |
| 222 | Phosphorylation | STDSVSDIVPDSPFP CCCCHHHCCCCCCCC | 3.64 | 27251275 | |
| 224 | Phosphorylation | DSVSDIVPDSPFPGA CCHHHCCCCCCCCCC | 36.37 | 27251275 | |
| 226 | Phosphorylation | VSDIVPDSPFPGALG HHHCCCCCCCCCCCC | 23.52 | 23927012 | |
| 230 | Phosphorylation | VPDSPFPGALGSDTR CCCCCCCCCCCCCCC | 33.54 | 27251275 | |
| 234 | Phosphorylation | PFPGALGSDTRTAGQ CCCCCCCCCCCCCCC | 36.34 | 20068231 | |
| 236 | Phosphorylation | PGALGSDTRTAGQPE CCCCCCCCCCCCCCC | 31.45 | 20068231 | |
| 253 | Phosphorylation | PGADFGQSCFPAEAG CCCCCCCCCCCHHCC | 20.36 | 26552605 | |
| 254 | Glutathionylation | GADFGQSCFPAEAGR CCCCCCCCCCHHCCC | 3.49 | 22555962 | |
| 263 | Phosphorylation | PAEAGRDTLSRTAGA CHHCCCCCHHCCCCC | 25.85 | 26552605 | |
| 265 | Phosphorylation | EAGRDTLSRTAGAQP HCCCCCHHCCCCCCC | 29.67 | 26552605 | |
| 309 | Phosphorylation | VELHTTESIDLDPTK EEEEECCEECCCCCC | 21.22 | 22468782 | |
| 315 | Phosphorylation | ESIDLDPTKPESASP CEECCCCCCCCCCCC | 59.92 | 26074081 | |
| 319 | Phosphorylation | LDPTKPESASPPADG CCCCCCCCCCCCCCC | 42.44 | 26074081 | |
| 321 | Phosphorylation | PTKPESASPPADGTG CCCCCCCCCCCCCCC | 40.47 | 27050516 | |
| 327 | Phosphorylation | ASPPADGTGSASGTL CCCCCCCCCCCCCCE | 28.63 | 26074081 | |
| 329 | Phosphorylation | PPADGTGSASGTLPV CCCCCCCCCCCCEEC | 21.06 | 26074081 | |
| 331 | Phosphorylation | ADGTGSASGTLPVSQ CCCCCCCCCCEECCC | 33.73 | 26074081 | |
| 333 | Phosphorylation | GTGSASGTLPVSQPK CCCCCCCCEECCCCC | 25.95 | 26074081 | |
| 337 | Phosphorylation | ASGTLPVSQPKSWAS CCCCEECCCCCCHHH | 38.53 | 26074081 | |
| 341 | Phosphorylation | LPVSQPKSWASLFHD EECCCCCCHHHHCCC | 34.26 | 25159151 | |
| 344 | Phosphorylation | SQPKSWASLFHDSKP CCCCCHHHHCCCCCC | 25.88 | 28464451 | |
| 349 | Phosphorylation | WASLFHDSKPSSSSP HHHHCCCCCCCCCCC | 37.59 | 26074081 | |
| 350 | Acetylation | ASLFHDSKPSSSSPV HHHCCCCCCCCCCCE | 55.78 | 25953088 | |
| 352 | Phosphorylation | LFHDSKPSSSSPVAY HCCCCCCCCCCCEEE | 46.73 | 20068231 | |
| 353 | Phosphorylation | FHDSKPSSSSPVAYV CCCCCCCCCCCEEEE | 43.28 | 25159151 | |
| 354 | Phosphorylation | HDSKPSSSSPVAYVE CCCCCCCCCCEEEEE | 42.89 | 25159151 | |
| 355 | Phosphorylation | DSKPSSSSPVAYVET CCCCCCCCCEEEEEE | 25.91 | 25159151 | |
| 359 | Phosphorylation | SSSSPVAYVETKYSP CCCCCEEEEEECCCC | 10.07 | 22115753 | |
| 362 | Phosphorylation | SPVAYVETKYSPPAI CCEEEEEECCCCCCC | 25.82 | 23898821 | |
| 363 | Acetylation | PVAYVETKYSPPAIS CEEEEEECCCCCCCC | 30.17 | 26051181 | |
| 364 | Phosphorylation | VAYVETKYSPPAISP EEEEEECCCCCCCCC | 33.55 | 19664994 | |
| 365 | Phosphorylation | AYVETKYSPPAISPL EEEEECCCCCCCCCC | 26.43 | 29255136 | |
| 369 | Phosphorylation | TKYSPPAISPLVSEK ECCCCCCCCCCCCCC | 5.56 | 27251275 | |
| 370 | Phosphorylation | KYSPPAISPLVSEKQ CCCCCCCCCCCCCCC | 17.81 | 19664994 | |
| 374 | Phosphorylation | PAISPLVSEKQVEVK CCCCCCCCCCCEEEE | 46.92 | 29255136 | |
| 376 | Acetylation | ISPLVSEKQVEVKEG CCCCCCCCCEEEECC | 52.73 | 25953088 | |
| 376 | Ubiquitination | ISPLVSEKQVEVKEG CCCCCCCCCEEEECC | 52.73 | - | |
| 381 | Ubiquitination | SEKQVEVKEGLVPVS CCCCEEEECCCEECC | 32.34 | - | |
| 395 | Ubiquitination | SEDPVAIKIAELLEN CCCHHHHHHHHHHHC | 26.57 | - | |
| 408 | Acetylation | ENVTLIHKPVSLQPR HCEEEECCCCCCCCC | 39.87 | 26051181 | |
| 408 | Ubiquitination | ENVTLIHKPVSLQPR HCEEEECCCCCCCCC | 39.87 | 21890473 | |
| 412 | Ubiquitination | LIHKPVSLQPRGLIN EECCCCCCCCCCCCC | 9.17 | 21890473 | |
| 456 (in isoform 2) | Ubiquitination | - | 5.24 | - | |
| 488 | Acetylation | PRQALGDKIVRDIRP CCCCCCCHHHHCCCC | 41.10 | 25953088 | |
| 488 | Ubiquitination | PRQALGDKIVRDIRP CCCCCCCHHHHCCCC | 41.10 | - | |
| 503 | Phosphorylation | GAAFEPTYIYRLLTV CCCCCCEEEEEEEEE | 13.48 | - | |
| 512 | Ubiquitination | YRLLTVNKSSLSEKG EEEEEECHHHCCHHC | 36.77 | - | |
| 513 | Phosphorylation | RLLTVNKSSLSEKGR EEEEECHHHCCHHCC | 31.16 | 29978859 | |
| 514 | Phosphorylation | LLTVNKSSLSEKGRQ EEEECHHHCCHHCCH | 37.21 | 29978859 | |
| 516 | Phosphorylation | TVNKSSLSEKGRQED EECHHHCCHHCCHHH | 38.93 | 29978859 | |
| 518 | Acetylation | NKSSLSEKGRQEDAE CHHHCCHHCCHHHHH | 56.89 | 25953088 | |
| 518 | Ubiquitination | NKSSLSEKGRQEDAE CHHHCCHHCCHHHHH | 56.89 | - | |
| 527 | Phosphorylation | RQEDAEEYLGFILNG CHHHHHHHHHHHHHH | 12.02 | - | |
| 536 (in isoform 2) | Ubiquitination | - | 30.30 | - | |
| 544 | Ubiquitination | EEMLNLKKLLSPSNE HHHHCHHHHHCCCCC | 58.80 | - | |
| 547 | Phosphorylation | LNLKKLLSPSNEKLT HCHHHHHCCCCCCCE | 36.40 | 29255136 | |
| 549 | Phosphorylation | LKKLLSPSNEKLTIS HHHHHCCCCCCCEEC | 55.00 | 23401153 | |
| 551 | Phosphorylation | KLLSPSNEKLTISNG HHHCCCCCCCEECCC | 54.50 | 27251275 | |
| 552 | Ubiquitination | LLSPSNEKLTISNGP HHCCCCCCCEECCCC | 56.00 | - | |
| 554 | Phosphorylation | SPSNEKLTISNGPKN CCCCCCCEECCCCCC | 33.17 | 26074081 | |
| 556 | Phosphorylation | SNEKLTISNGPKNHS CCCCCEECCCCCCCC | 30.42 | 25159151 | |
| 563 | Phosphorylation | SNGPKNHSVNEEEQE CCCCCCCCCCHHHHH | 35.71 | 23927012 | |
| 576 | Phosphorylation | QEEQGEGSEDEWEQV HHHCCCCCHHHHHHC | 37.26 | 22167270 | |
| 580 | Phosphorylation | GEGSEDEWEQVGPRN CCCCHHHHHHCCCCC | 17.40 | 27251275 | |
| 600 | Phosphorylation | RQADFVQTPITGIFG HHHCCEECCCCCCCC | 16.03 | 27251275 | |
| 600 (in isoform 2) | Ubiquitination | - | 16.03 | - | |
| 604 | Phosphorylation | FVQTPITGIFGGHIR CEECCCCCCCCCEEE | 17.59 | 27251275 | |
| 615 | Nitration | GHIRSVVYQQSSKES CEEEEEEEECCCCCC | 9.93 | - | |
| 659 | Phosphorylation | ARESVQGYTTKTKQE HHHHHCCCCCCCCCE | 8.31 | - | |
| 662 | Acetylation | SVQGYTTKTKQEVEI HHCCCCCCCCCEEEE | 46.02 | 25953088 | |
| 662 | Ubiquitination | SVQGYTTKTKQEVEI HHCCCCCCCCCEEEE | 46.02 | - | |
| 664 | Ubiquitination | QGYTTKTKQEVEISR CCCCCCCCCEEEEEE | 46.12 | - | |
| 670 | Phosphorylation | TKQEVEISRRVTLEK CCCEEEEEECCCHHH | 10.67 | - | |
| 674 | Phosphorylation | VEISRRVTLEKLPPV EEEEECCCHHHCCCE | 27.64 | - | |
| 677 | Acetylation | SRRVTLEKLPPVLVL EECCCHHHCCCEEEE | 70.21 | 26051181 | |
| 677 | Ubiquitination | SRRVTLEKLPPVLVL EECCCHHHCCCEEEE | 70.21 | - | |
| 687 | Acetylation | PVLVLHLKRFVYEKT CEEEEEEEEHHHHHC | 32.80 | 25953088 | |
| 691 | Phosphorylation | LHLKRFVYEKTGGCQ EEEEEHHHHHCCCHH | 14.70 | 21214269 | |
| 693 | Acetylation | LKRFVYEKTGGCQKL EEEHHHHHCCCHHHH | 34.48 | 25953088 | |
| 693 | Malonylation | LKRFVYEKTGGCQKL EEEHHHHHCCCHHHH | 34.48 | 26320211 | |
| 693 | Ubiquitination | LKRFVYEKTGGCQKL EEEHHHHHCCCHHHH | 34.48 | - | |
| 694 | Phosphorylation | KRFVYEKTGGCQKLI EEHHHHHCCCHHHHH | 27.20 | 21214269 | |
| 699 | Acetylation | EKTGGCQKLIKNIEY HHCCCHHHHHHCCCC | 57.14 | 25953088 | |
| 699 | Ubiquitination | EKTGGCQKLIKNIEY HHCCCHHHHHHCCCC | 57.14 | - | |
| 702 | Acetylation | GGCQKLIKNIEYPVD CCHHHHHHCCCCCCC | 63.41 | 26051181 | |
| 702 | Ubiquitination | GGCQKLIKNIEYPVD CCHHHHHHCCCCCCC | 63.41 | - | |
| 710 (in isoform 2) | Ubiquitination | - | 6.83 | - | |
| 712 (in isoform 2) | Ubiquitination | - | 10.42 | - | |
| 713 | Phosphorylation | YPVDLEISKELLSPG CCCCHHHCHHHCCCC | 15.65 | 18669648 | |
| 714 | Acetylation | PVDLEISKELLSPGV CCCHHHCHHHCCCCC | 59.03 | 23954790 | |
| 714 | Ubiquitination | PVDLEISKELLSPGV CCCHHHCHHHCCCCC | 59.03 | - | |
| 718 | Phosphorylation | EISKELLSPGVKNKN HHCHHHCCCCCCCCC | 32.03 | 30266825 | |
| 722 | Phosphorylation | ELLSPGVKNKNFKCH HHCCCCCCCCCCEEC | 69.03 | 27251275 | |
| 722 | Ubiquitination | ELLSPGVKNKNFKCH HHCCCCCCCCCCEEC | 69.03 | - | |
| 725 (in isoform 2) | Ubiquitination | - | 51.51 | - | |
| 741 (in isoform 2) | Malonylation | - | 21.31 | 26320211 | |
| 741 (in isoform 2) | Ubiquitination | - | 21.31 | - | |
| 750 (in isoform 2) | Ubiquitination | - | 18.01 | - | |
| 762 (in isoform 2) | Ubiquitination | - | 4.96 | - | |
| 769 | Phosphorylation | WLRIDDQTVKVINQY EEEECCCEEEEEEEE | 29.32 | 28258704 | |
| 771 | Acetylation | RIDDQTVKVINQYQV EECCCEEEEEEEEEE | 40.56 | 26051181 | |
| 780 | Acetylation | INQYQVVKPTAERTA EEEEEEECCCHHHEE | 37.48 | 26822725 | |
| 780 | Ubiquitination | INQYQVVKPTAERTA EEEEEEECCCHHHEE | 37.48 | 2190698 | |
| 786 | Phosphorylation | VKPTAERTAYLLYYR ECCCHHHEEEEEEEE | 15.91 | 28152594 | |
| 788 | Phosphorylation | PTAERTAYLLYYRRV CCHHHEEEEEEEEEC | 9.16 | 28152594 | |
| 791 | Phosphorylation | ERTAYLLYYRRVDLL HHEEEEEEEEECCCC | 7.73 | 28176443 | |
| 792 | Phosphorylation | RTAYLLYYRRVDLL- HEEEEEEEEECCCC- | 7.60 | 28176443 | |
| 828 (in isoform 2) | Malonylation | - | 26320211 | ||
| 828 (in isoform 2) | Ubiquitination | - | - |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of UBP10_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of UBP10_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "USP10 regulates p53 localization and stability by deubiquitinatingp53."; Yuan J., Luo K., Zhang L., Cheville J.C., Lou Z.; Cell 140:384-396(2010). Cited for: FUNCTION, CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, INDUCTION,INTERACTION WITH TP53, PHOSPHORYLATION AT THR-42; SER-337 AND CYS-424,AND MUTAGENESIS OF THR-42 AND SER-337. | |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-563 AND SER-576, ANDMASS SPECTROMETRY. | |
| "Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-576, AND MASSSPECTROMETRY. | |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-208; SER-365; SER-370;SER-547 AND SER-576, AND MASS SPECTROMETRY. | |
| "Large-scale phosphoproteome analysis of human liver tissue byenrichment and fractionation of phosphopeptides with strong anionexchange chromatography."; Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,Zou H., Gu J.; Proteomics 8:1346-1361(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-576, AND MASSSPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-100; SER-220; SER-226;SER-370; SER-563 AND SER-576, AND MASS SPECTROMETRY. | |
| "Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-576, AND MASSSPECTROMETRY. | |
| "Quantitative phosphoproteome profiling of Wnt3a-mediated signalingnetwork: indicating the involvement of ribonucleoside-diphosphatereductase M2 subunit phosphorylation at residue serine 20 in canonicalWnt signal transduction."; Tang L.-Y., Deng N., Wang L.-S., Dai J., Wang Z.-L., Jiang X.-S.,Li S.-J., Li L., Sheng Q.-H., Wu D.-Q., Li L., Zeng R.; Mol. Cell. Proteomics 6:1952-1967(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-576, AND MASSSPECTROMETRY. | |
| "Toward a global characterization of the phosphoproteome in prostatecancer cells: identification of phosphoproteins in the LNCaP cellline."; Giorgianni F., Zhao Y., Desiderio D.M., Beranova-Giorgianni S.; Electrophoresis 28:2027-2034(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-576, AND MASSSPECTROMETRY. | |
| "A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-364; SER-365 ANDSER-370, AND MASS SPECTROMETRY. | |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-576, AND MASSSPECTROMETRY. | |
| "Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-211 AND SER-576, ANDMASS SPECTROMETRY. | |